Contact Information
Company Information
Company
Mersana Therapeutics
Annual Revenue
40500000.0
Technologies
Mimecast
Google Cloud Hosting
New Relic
WordPress.org
Mobile Friendly
Vimeo
Google Analytics
Google Font API
Nginx
Google Tag Manager
Remote
AI
Keywords
cancer research
antibody drug conjugates
drug development
bioconjugation
oncology
biotechnology
life sciences
biotechnology: pharmaceutical preparations
health care
biotechnology research
antibody-drug conjugates
adcs
cancer therapeutics
dolasynthen
immunosynthen
pipeline development
cytotoxic payloads
immunostimulatory drugs
drug optimization
target antigen
novel cancer therapies
onco-targeting
b7-h4
her2 target
personalized medicine
clinical trials
oncology drug development
collaborative research
biopharmaceutical innovation
patient-centric solutions
cancer treatment
drug delivery systems
biologics
targeted therapy
clinical-stage
scientific excellence
regulatory affairs
medical advancements
therapeutic windows
reduced toxicity
life-changing therapies
multi-pronged strategy
stakeholder engagement
cancer care
research & development
commercialization
biotech industry
scientific advisory board
patient access
diversity & inclusion
corporate responsibility
sustainability efforts
community engagement
healthcare innovation
biopharmaceutical
immunostimulatory payloads
novel therapies
targeted therapies
solid tumors
her2-negative breast cancer
triple-negative breast cancer
innovative technology
patient-centric
strategic partnerships
merck kgaa
gsk
takeda
johnson & johnson
unmet medical needs
patient demographics
global expansion
scientific innovation
fleximer platform
therapeutic efficacy
safety profiles
collaboration
transformative therapies
patient outcomes
hospital & health care
health
wellness & fitness
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans